| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 483 | 2017 |
| The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells L Dou, N JOURDE‐CHICHE, V Faure, C Cerini, Y Berland, ... Journal of Thrombosis and Haemostasis 5 (6), 1302-1308, 2007 | 453 | 2007 |
| Endothelium structure and function in kidney health and disease N Jourde-Chiche, F Fakhouri, L Dou, J Bellien, S Burtey, M Frimat, ... Nature Reviews Nephrology 15 (2), 87-108, 2019 | 375 | 2019 |
| Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures L Chiche, N Jourde‐Chiche, E Whalen, S Presnell, V Gersuk, K Dang, ... Arthritis & rheumatology 66 (6), 1583-1595, 2014 | 375 | 2014 |
| Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled … P Charles, B Terrier, É Perrodeau, P Cohen, S Faguer, A Huart, ... Annals of the rheumatic diseases 77 (8), 1143-1149, 2018 | 298 | 2018 |
| The cardiovascular effect of the uremic solute indole-3 acetic acid L Dou, M Sallée, C Cerini, S Poitevin, B Gondouin, N Jourde-Chiche, ... Journal of the American society of nephrology 26 (4), 876-887, 2015 | 293 | 2015 |
| Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway B Gondouin, C Cerini, L Dou, M Sallée, A Duval-Sabatier, A Pletinck, ... Kidney international 84 (4), 733-744, 2013 | 238 | 2013 |
| Mortality associated with systemic lupus erythematosus in France assessed by multiple‐cause‐of‐death analysis G Thomas, J Mancini, N Jourde‐Chiche, G Sarlon, Z Amoura, JR Harlé, ... Arthritis & rheumatology 66 (9), 2503-2511, 2014 | 211 | 2014 |
| Acute renal infarction: a case series M Bourgault, P Grimbert, C Verret, J Pourrat, M Herody, JM Halimi, ... Clinical Journal of the American Society of Nephrology 8 (3), 392-398, 2013 | 209 | 2013 |
| Vascular incompetence in dialysis patients—protein‐bound uremic toxins and endothelial dysfunction N Jourde‐Chiche, L Dou, C Cerini, F Dignat‐George, P Brunet Seminars in dialysis 24 (3), 327-337, 2011 | 199 | 2011 |
| Progress in uremic toxin research: protein‐bound toxins—update 2009 N Jourde‐Chiche, L Dou, C Cerini, F Dignat‐George, R Vanholder, ... Seminars in dialysis 22 (4), 334-339, 2009 | 190 | 2009 |
| Does uremia cause vascular dysfunction P Brunet, B Gondouin, A Duval-Sabatier, L Dou, C Cerini, ... Kidney and blood pressure research 34 (4), 284-290, 2011 | 185 | 2011 |
| The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty‐seven patients M Jachiet, B Flageul, A Deroux, A Le Quellec, F Maurier, F Cordoliani, ... Arthritis & rheumatology 67 (2), 527-534, 2015 | 164 | 2015 |
| Characteristics and management of IgA vasculitis (Henoch‐Schönlein) in adults: data From 260 patients included in a french multicenter retrospective survey A Audemard‐Verger, B Terrier, A Dechartres, J Chanal, Z Amoura, ... Arthritis & rheumatology 69 (9), 1862-1870, 2017 | 141 | 2017 |
| Circulating endothelial cells as a marker of endothelial injury in severe COVID-19 C Guervilly, S Burtey, F Sabatier, R Cauchois, G Lano, E Abdili, F Daviet, ... The Journal of infectious diseases 222 (11), 1789-1793, 2020 | 129 | 2020 |
| Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients N JOURDE‐CHICHE, L Dou, F Sabatier, R Calaf, C Cerini, S Robert, ... Journal of Thrombosis and Haemostasis 7 (9), 1576-1584, 2009 | 128 | 2009 |
| Clinical and genetic spectrum of Bartter syndrome type 3 E Seys, O Andrini, M Keck, L Mansour-Hendili, PY Courand, C Simian, ... Journal of the American Society of Nephrology 28 (8), 2540-2552, 2017 | 123 | 2017 |
| Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome J Zuber, M Frimat, S Caillard, N Kamar, P Gatault, F Petitprez, L Couzi, ... Journal of the American Society of Nephrology 30 (12), 2449-2463, 2019 | 97 | 2019 |
| Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease L Dou, S Poitevin, M Sallée, T Addi, B Gondouin, N McKay, MS Denison, ... Kidney international 93 (4), 986-999, 2018 | 97 | 2018 |
| Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors A Le Clech, N Simon-Tillaux, F Provôt, Y Delmas, P Vieira-Martins, ... Kidney international 95 (6), 1443-1452, 2019 | 95 | 2019 |
